LNAINasdaqPharmaceutical PreparationsFiscal year ends June 30
Lunai Bioworks Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$0.47−0.21 (-30.63%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 22, 2026 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Nov 14, 2025(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Sep 30, 2025 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |